| AD | Alzheimer’s disease |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| BPSDs | Behavioral and Psychological Symptoms of Dementia |
| BA | Brodmann area |
| BEO | Bergamot essential oil |
| CNS | Central Nervous System |
| GABA | γ-aminobutyric acid |
| mTOR | mammalian target of rapamycin |
| MCI | Mild cognitive impairment |
| MMSE | Mini-Mental State Examination |
| NAADP | Nicotinic acid adenine dinucleotide phosphate |
| NMDA | N-methyl-D-aspartate |
| NPI | Neuropsychiatric Inventory |
| NPSs | Neuropsychiatric Symptoms |
| QoL | Quality of life |
| 5-HT | Serotonin |
| ZnT3 | Synaptic vesicle zinc transporter |
| TRPV1 | Type 1 vanilloid receptor |
| UCLA-ADRC | University of California, Los Angeles Alzheimer Disease Research Center |